Short answer · Medically reviewed summary · Last updated: 2026-04-08
Fuchs dystrophy is primarily classified under the ICD-10 code H18.51 (Endothelial corneal dystrophy), while its historical ICD-9 code is 371.57. These diagnostic codes are essential for insurance billing and clinical documentation, helping healthcare providers track the progression and management of this progressive corneal condition. What is Fuchs dystrophy and how is it classified? Fuchs dystrophy, also known as Fuchs endothelial corneal dystrophy (FECD), is a bilateral, slowly progressive disease affecting the innermost layer of the cornea, the endothelium.
2 people with Fuchs dystrophy have shared their first-person experience on this question at DiseaseMaps.
Fuchs dystrophy is primarily classified under the ICD-10 code H18.51 (Endothelial corneal dystrophy), while its historical ICD-9 code is 371.57. These diagnostic codes are essential for insurance billing and clinical documentation, helping healthcare providers track the progression and management of this progressive corneal condition.
Fuchs dystrophy, also known as Fuchs endothelial corneal dystrophy (FECD), is a bilateral, slowly progressive disease affecting the innermost layer of the cornea, the endothelium. This layer is responsible for pumping fluid out of the cornea to maintain clarity; when these cells deteriorate, fluid accumulates, leading to swelling (edema), blurred vision, and eventual vision loss. Because it is a specific type of endothelial corneal dystrophy, it is consistently categorized under ICD-10 code H18.51. Understanding these codes is a practical step for patients at DiseaseMaps.org, where 99 members have already connected to share their experiences with this condition.
The progression of Fuchs dystrophy is typically categorized into stages, which clinicians use to determine the appropriate course of treatment. The disease is characterized by the formation of "guttata"—small, wart-like deposits on the posterior surface of the cornea. As the disease advances, these physical changes lead to functional impairment. The clinical stages generally include:
Yes, Fuchs dystrophy has a strong genetic component, though it is often considered a complex trait rather than a simple Mendelian disorder. Many cases are associated with mutations in the TCF4 gene. Family history is a significant risk factor, and the condition is frequently diagnosed in individuals between the ages of 50 and 60, though early-onset forms can occur. Genetic counseling is often recommended for families with a high prevalence of Fuchs dystrophy to understand the risk of inheritance and the variable expressivity of the condition.
Management of Fuchs dystrophy is highly individualized based on the severity of the corneal edema. In the early stages, conservative management using hypertonic saline drops or ointments can help draw fluid out of the cornea. As the disease progresses, surgical intervention often becomes necessary. Modern surgical options, such as Descemet Membrane Endothelial Keratoplasty (DMEK) and Descemet Stripping Automated Endothelial Keratoplasty (DSAEK), have revolutionized the prognosis for patients by replacing only the diseased endothelial layer rather than performing a full-thickness corneal transplant.
Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.